News
3d
TipRanks on MSNAbbVie’s Promising Phase 3 Study on Upadacitinib for Alopecia AreataAbbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
4d
Zacks.com on MSNShould You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?TMO's growth via acquisitions and product launches is strong, but macro pressures and FX headwinds cloud the outlook.
Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant. The European Commission has ...
India's Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss.
Use of lasers for dermatologic conditions in pediatric patients brings challenges, from psychosocial and informed consent ...
5d
US Weekly on MSNMoriah Plath Shares ‘Vulnerable’ Journey With Alopecia After Losing Hair, EyebrowsMoriah Plath of 'Welcome to Plathville' shares her emotional journey with alopecia after losing her hair, eyebrows and ...
Landon Jackson was diagnosed with alopecia at five years old. Even as he begins his rookie season in the NFL, he still ...
Hair loss and baldness are more treatable than ever. Learn about hair loss prevention, treatment options for alopecia, male pattern baldness, hair loss in women, and thinning hair in both men and ...
Find dermatology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.
Psychiatric Annals | Find psychiatric news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles from the #1 online source for psychiatrists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results